Gastro-esophageal Reflux Disease (GERD) Terminated Phase 3 Trials for Aluminum hydroxide (DB06723)

Back to Gastro-esophageal Reflux Disease (GERD)

Also known as: Esophageal Reflux / Gastroesophageal Reflux Disease / Gastrooesophageal reflux disease / Gastro-Oesophageal Reflux Disease / Gastro-esophageal Reflux Disease / Gastro-esophageal Reflux Diseases / GERD Gastroesophageal Reflux Disease / GERD (Gastroesophageal Reflux Disease) / GERD / GERD - Gastro-Esophageal Reflux Disease / Gastroesophageal Reflux Disease (GERD) / Oesophageal reflux / Esophagitis / Gastrooesophageal reflux / Gastroesophageal reflux / Esophageal reflux NOS

Indication	Status	Phase
DBCOND0077290 (Gastro-esophageal Reflux Disease (GERD))	Terminated	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02619747	Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients	Other	Alginic acid (DB13518) Aluminum hydroxide (DB06723) Magnesium carbonate (DB09481)